24 June 2021 - Deborah Wilkes
Premium
GlaxoSmithKline (GSK) has confirmed plans to demerge its Consumer Healthcare business in mid 2022. The company says New Consumer Healthcare will have 20 brands each with sales in excess of GBP100 million (USD140 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.